Modeyso is the first FDA-approved systemic therapy for H3 K27M-mutant diffuse midline glioma, targeting both adult and pediatric patients. Clinical trials demonstrated a 22% overall response rate with ...

Diffuse optical techniques have proven to be valuable methods for non-invasively observing blood flow in living subjects. A number of modalities have been developed, with diffuse correlation ...

It is, I believe, generally recognized that collaboration among funders is important, because none of us has the resources to make serious inroads on big problems by ourselves. Yet despite widespread ...

Diffuse large B-cell lymphoma is a common type of non-Hodgkin’s lymphoma that also has a high rate of relapse. Common signs of a relapse include lymph node swelling, as well as the development of “B ...